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ABSTRACT The UK and Spanish Stem Cell Banks hold politically controversial—but
potentially therapeutically beneficial—human embryonic stem cells for distribution to
research laboratories globally. The UK bank was the first of its type in the world,
opening in 2004, and the Spanish bank used it as a role model in its own development.
Both banks structure their operations in response to how their staffs imagine the
publics in their nation make trust judgements about their work. Differences between the
workings of each bank can be traced to differences in the collective imaginings
operating at each bank—termed ‘institutional imaginaries’—about how publics think.
The UK bank sustains an imaginary in which distance lends legitimacy and
disengagement signifies correct moral practice. It conjures a public that values a
steady, safe and reliable institution—free from potential conflict of interest—about
which the less news the better. This stands in contrast to the Spanish bank that conjures
a public that retains an interest in legitimate, ethical guardianship of stem cell
material, but which is less worried about conflict of interest in attaining this. Instead,
for the Spanish institution, engagement with science and the media through the
projection of the bank as cutting edge is deemed crucial for maintaining public support.
KEY WORDS: Publics, stem cell banks, UK, Spain, imaginaries
Introduction
The last 10 years have seen the emergence of a number of stem cell banks across
the world. Their formations differ, but their general purpose is to assemble deposits
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of human embryonic, adult and induced pluripotency stem cells, to test these
deposits for purity and sterility, and to distribute these materials to research labora-
tories.1 These activities are important for two reasons. First, they are intended to
address the high profile ethical controversies about the sourcing of human embryo-
nic stem cells that inherently involve the destruction of embryos (Holm, 2002).
Second, they are intended to supply high quality material to biomedical researchers
facilitating the development of new therapeutic advances in disease management.
Both are publicly important issues. In this article we focus on two banks: the first to
be established—the UK Stem Cell Bank—and its counterpart in Spain.
The UK Stem Cell Bank was established in 2002 and opened in 2004. It was
endorsed by the House of Lords’ Stem Cell Research Select Committee (2002)
that advocated that the bank should have a steer on ethical debates around
human embryonic stem cell (hESC) lines. It was anticipated that by providing a
centralised location for the storage and distribution of hESC lines the bank
would lessen the numbers of embryos destroyed by enabling a number of research-
ers to work with material from any one donation.
The profile and success of the UK Stem Cell Bank has fostered the emergence
of a range of related human embryonic stem cell banks across the globe. Never-
theless, there is great diversity in their cultural contexts and in how these different
banks operate. A working group—the International Stem Cell Banking Initiative
(ISCBI)—exists to encourage the sharing of best practice and it endeavours to har-
monise ethical and technical standards (Isasi and Knoppers, 2009; Stephens et al.,
2011b; Hammond-Browning and Stephens, 2013). Institutions involved are from
North America, Europe and Asia and they exhibit wide diversity in practice,
including public and private funding and distributing different types of cells,
which are deposited through different procedures.
Inside the UK Stem Cell Bank: human embryonic stem cell lines are stored for international
distribution.
498 N. Stephens et al.
D
ow
nl
oa
de
d 
by
 [C
ard
iff
 U
niv
ers
ity
] a
t 0
7:0
8 2
2 J
an
ua
ry
 20
14
 
In contrast to this diversity, the two banks we focus on here, those in the UK and
in Spain, have much in common. Both are based in European democracies with
relatively permissive regulatory environments for hESC research (Elstner et al.,
2009). In this respect they are in contrast with those of Germany or Italy, for
example, where hESC research is heavily restricted, or India, where researchers
are free from the regulative scrutiny experienced by British and Spanish research-
ers (Bharawaj and Glasner, 2009). Both banks are publicly funded, non-profit
organisations, opened since 2004 as repositories for human embryonic and adult
stem cells. As a result of the Spanish bank modelling itself on the UK bank,
both institutions have ethical oversight steering committees operating above the
laboratory organisational structure. From a broader perspective, both institutions
are regarded as drivers and symbols of their nation’s world-leading science
portfolios.
In this article we ask how the form and activities undertaken by these banks are
shaped by their assumptions about how the publics in their countries form trust
judgements about scientific issues. How do the banks model publics and their con-
cerns? How do they see themselves as publicly accountable? What different pat-
terns arise in the two national cases? How can these differences be explained? We
argue that, while the Spanish Stem Cell Bank has adopted the UK banking model,
the local political and social context in Spain resulted in distinctive configurations
of their accountability practices that differ from those in the UK. We develop the
analytical perspective of Jasanoff and Kim (2009) in describing these banks as
holding institutional sociotechnical imaginaries of the publics with which they
operate.
We base this argument upon our empirical work undertaken during a three-year
ethnographic study of the UK Stem Cell Bank conducted in 2005–2008 (Stephens
et al., 2008a, 2008b, 2011a, 2011b, 2012; Stacey and Stephens, 2012; Stephens,
2012). The project involved 36 interviews with the UK Stem Cell Bank staff and
steering committee members and two fieldtrips to the Spanish Stem Cell Bank in
Granada, Barcelona and Madrid. The interviews were conducted in 2007, so the
value of this article derives from its analytical account, rather than from the up-
to-the-minuteness of the institutional description. Interviews were conducted in
English by Neil Stephens, a British-born, native English speaker. Interviewees
were offered personal anonymity in publication—in as much as this is achiev-
able—to protect the full range of individuals working at each institution.
In what follows we will contrast the banks’ organisational structures and use
extracts from our interviews with the banks’ employees to probe the ways in
which each bank’s institutional imaginary of the public frames their operations.
Analytical Perspectives: Institutional Imaginaries of Publics
A productive analytical perspective for discussing the work of the banks con-
sidered here has been developed by Sheila Jasanoff and Sang-Hyun Kim. They
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develop the concept of ‘sociotechnical imaginary’, defined as ‘collectively ima-
gined forms of social life and social order reflected in the design and fulfilment
of nation-specific scientific and/or technological projects’ (Jasanoff and Kim,
2009, p. 120). This concept acknowledges the constitutive role of the capacity
to imagine futures in scientific, social and political activity, whereby ‘technoscien-
tific imaginaries are simultaneously also “social imaginaries”, encoding collective
visions of the good society’ (Jasanoff and Kim, 2009, p. 123). The concept is
specifically orientated towards making comparisons between countries to
provide nuanced analysis of national variations in technology policies.
However, in this paper we offer a more focused analysis as befits our empirical
material. Our analysis compares ethnographic reports from two institutions—the
UK and Spanish stem cell banks. Hence, instead of invoking national sociotech-
nical imaginaries, we describe the institutional sociotechnical imaginaries, here-
after institutional imaginaries, enacted in each bank. These are the collectively
imagined forms of social life and social order reflected in the design and realis-
ation of institutionally based scientific projects—in this case, stem cell banking.
The collectives forming these imaginaries are those working with and within
these institutions. This contrasts with Jasanoff and Kim’s focus on entire nation
states and nation state building. The focus here is on what the institutions are
intending to achieve, the mechanisms deemed appropriate to do so, and how
these mechanisms are put into place. This allows us to describe institutions as
articulations of particular institutional imaginaries.
Our focus is on the form taken by the institutional imaginaries of publics
enacted at each bank. We explore how our ethnographic data about the operations
of each bank reveal mechanisms shaped by how the staff at each bank imagines
publics within their own country. We identify instances in which assumptions
about how publics make trust judgements about scientific endeavour influence
each bank’s practice and institutional form. In this regard the paper is not directly
about Spanish and UK publics themselves, but about how they are imagined
within the banks and what difference this imagination makes.
Jasanoff and Kim’s (2009) work on imaginaries has already been deployed in a
number of other research projects. Their own empirical work develops an account of
the US and South Korean national imaginaries around nuclear energy, as ‘atoms for
peace’ and ‘atoms for development’, respectively, that frame sociotechnical activity
and public response in each nation. Bouzarovski and Bassin (2011) also reflect upon
energy through a focus on the Putinist imaginary around global Russian hydro-
carbon supremacy. They highlight the entanglement of discursive and material
aspects of the hydrocarbon landscape within a particular vision of national identity.
Felt and Mu¨ller (2011) note the relatedness of sociotechnical imaginaries to ‘tech-
nopolitical cultures’ through their analysis of patient sense-making of genetic
testing in dealing with hereditary forms of breast and ovarian cancer in Austria.
This analysis is expanded to include organ donation in Austria, France and the
Netherlands (Felt et al., 2010) and skin donation in Austria (Felt et al., 2009).
500 N. Stephens et al.
D
ow
nl
oa
de
d 
by
 [C
ard
iff
 U
niv
ers
ity
] a
t 0
7:0
8 2
2 J
an
ua
ry
 20
14
 
The theme of genetic counselling is also employed by Rommetveit (2011) who ana-
lyses the ‘enhancement imaginary’ constructed in Western discourses about genetic
information flows, identifying them as moving from a ‘social imaginary’ (Taylor,
2004) to a ‘sociotechnical imaginary’—implying a new-found institutional and
technoscientific capacity from the 1970s onwards.
In work similar to the research presented in this article, Pickersgill (2011)
extends Jasanoff and Kim’s work to explore sociotechnical imaginaries in more
micro-social processes. His analysis is of an emerging imaginary around neuro-
science and the law with a particular focus on free-will and detecting deception.
He explores visions of technological development and social order that emerge
through the discourses of individuals and transnational collectives rather than
nation states. Except for the articles by Jasanoff and Kim (2009) and Bouzarovski
and Bassin (2011), all of these studies shift the emphasis away from national
sociotechnical imaginaries to those conjured by patients, academic communities
or constellations of the two. We make a similar move by focusing on the insti-
tutional imaginaries of the stem cell banks we researched. However, unlike the
various other projects discussed here, our analysis highlights how publics are
imagined within these micro-social institutions.
Empirical Analysis: Organisational Structures of the Stem Cell Banks
The UK Stem Cell Bank
UK Stem Cell Bank representatives always make it clear that their bank has two
parts. The first is the laboratory space housed at a biological standards agency—
the National Institute for Biological Standards and Control (NIBSC)—that con-
ducts the day-to-day work of banking, testing and distributing stem cells. The
second is the ‘steering committee’: the ethical oversight group that judges the suit-
ability of each deposit and accession at the bank, as well as overseeing the bank’s
remit. The two parts are designed as separate, with no crossover of role, location or
personnel. Indeed, the individuals making up the steering committee are strangers
to the majority of laboratory staff. The director of the bank is not a member of the
steering committee, and, at first, was not even allowed to attend their meetings, as
a member of the committee’s secretariat explained:
There needs to be a separation between the operation of the bank and the
oversight of the bank. But then, the bank needs to know what the oversight
says and whether it is implementable. So a slight change when I took over
was that the people from the bank were not in attendance in the committee.
I couldn’t see why . . . so they’re present throughout the meeting now.
Once the director of the bank started attending steering committee meetings, our
ethnographic observation confirmed that he maintained his role as distinct from
Institutional Imaginaries of Publics in Stem Cell Banking 501
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that of the members of the steering committee. The following account provided by
the director of the UK bank confirms this:
We are certainly not in any way critical to, or even contributory to, the
decisions on the ethical nature of the materials that come into the bank.
We are purely there to comment on the technical and operational issues
that may relate to a new cell line coming into the bank . . . we’ll respond
to specific questions, not all of the questions but some . . . but that is advisory
to the steering committee.
This approach is intended to demonstrate the bank’s legitimacy. The rationale is to
prevent conflict of interest so that decisions about the UK Stem Cell Bank are not
made by those who work there, as it was considered that this could compromise
their decisions (Steering Committee, 2004). Such practices and structures are
not unusual in UK bio-political decision making, including in the structure of
science regulatory and funding bodies that also engage with the bank (Jones
and Salter, 2003; Jasanoff, 2005).
The steering committee membership—which includes those formally privi-
leged with decision-making powers—consists of an interdisciplinary group of
life scientists, ethicists, social scientists, clinicians and ‘lay representatives’, the
latter usually being members of patient groups. All are unpaid. This is intended
to ensure transparency and democracy, with the various groups, who represent
diverse interests, both scrutinising and informing the decision-making process
(Stephens et al., 2008b, 2011a, 2011b).
Concern to prevent conflict of interest is evident in the Code of Practice for the
Use of Human Stem Cell Lines produced by the bank’s steering committee:
The bank has been located in an independent national institution to avoid
potential conflict of interest. It will not receive or store human embryos
and will not conduct discovery research on the banked stem cell lines; the
staff may however, pursue research aimed at improving banking processes
and procedures. (Steering Committee for the UK Stem Cell Bank and For
the Use of Stem Cell Lines, 2005, p. 9)
The bank’s own Code of Practice, a related document also produced by the steer-
ing committee, outlines a similar mode of operation:
[T]he bank would need to be sited in an independent national laboratory to
avoid the potential conflicts of interest that would occur if the bank were
placed in an academic lab engaged in full time stem cell research (Steering
Committee for the UK Stem Cell Bank and For the Use of Stem Cell Lines,
2004, p. 12).
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By prohibiting research and derivation, all of the material held in the bank must
come from elsewhere and then be deposited in the bank. In this way the very phy-
sicality of the bank performs legitimate practice (Stephens et al., 2008a; Stephens,
2012). Both of these provisions stop the bank from competing with the labora-
tories that deposit or access material stored in their premises. Such competition,
it is believed, would compromise the legitimacy of the bank as a guardian of
stem cell material. As we will demonstrate below, the institutional imaginary of
the public mobilised in Spanish stem cell banking configures these issues in a
quite different way.
The Spanish Stem Cell Bank
The Spanish bank modelled itself on the UK bank, with its staff making visits to
learn about UK practice, and producing a declaration of intent to support sub-
sequent collaboration and training (Banco de lı´neas celulares de Andalucı´a,
2004). However, the UK format was adapted to suit the Spanish context. The
first and most notable adaptation resulted from Spain’s political system of auton-
omous regions. There are 17 of these and two autonomous cities, established fol-
lowing the fiebre autono´mica (autonomy fever) during the closing stages of
Franco’s dictatorship (Hooper, 2006). Today each autonomy has political and
administrative control over aspects of bioscience regulation and funding. The
Spanish Stem Cell Bank is located in four different autonomous regions, with
three laboratory ‘nodes’ and one administrative centre. The lead node in
Granada, capital city of the autonomous region of Andalusia, was developed
specifically to host stem cell banking activity. The remaining two nodes are in
Barcelona and Valencia, in the autonomous regions of Catalonia and Valencia,
respectively. These are hosted by laboratories which were already working in
IVF and regenerative medicine. The administrative work of the bank is conducted
in Madrid, the centre of Spanish government and the location for the bank’s steer-
ing committee.
In 2007—when the research presented here was undertaken—the three nodes
worked to store hESC material for wider distribution within and beyond Spain.
However, in contrast to the UK bank, the Spanish nodes are intended to be
research active, as is evident in the Granada node’s medium to long-term
aims recorded in a document titled, Andalucia: The Place to be for Stem Cell
Research:
1. To have in place a strong and competitive network of national and international
stem cell researches.
2. To become an international hub for stem cell research efforts.
3. To translate basic research results into industrial and/or therapeutic
applications.
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4. To make a huge impact in the multidisciplinary fields other than regenerative
medicine such as embryology, drug screening and oncology (Bancelan, n.d.,
p. 8, typographical error in original).
All of these aims contravene the rules adopted in the UK context. Furthermore,
the Spanish nodes are also allowed to derive hESC lines themselves, meaning that
they take donations of ethically sourced human embryos and destroy them in order
to extract stem cells. The Valencia and Barcelona nodes have done so since early
in the bank’s development. Indeed, staff at the Granada node have conducted
socio-legal research into techniques for making the estimated 100,000 frozen
IVF embryos in Spanish IVF clinics available for hESC derivation (Cortes
et al., 2007). During a visit to the node, bank staff were preparing to house signifi-
cant quantities of these frozen embryos within their storage space so they could
proceed with in-house derivation imminently. Such involvement in increasing
the supply of embryos to stem cell research would be unthinkable at the UK
bank. It would not demonstrate distance between those who make ethical
decisions and those who act upon them and it would put the bank into competition
with other laboratories. However, in Spain, as we demonstrate further below, the
bank’s institutional imaginary is of a public keen to see scientific engagement and
Spanish leadership. Given this, it was seen to be appropriate for the Spanish bank
to derive their own lines as an articulation of a cutting-edge stem cell science
portfolio.
The Spanish bank adopted and modified a number of the UK laboratory prac-
tices. More importantly in our context, they also introduced alterations to the
UK model for the steering committee. In 2007, Spain had a smaller steering com-
mittee, consisting of eight people: two external life scientists, three representatives
of the Carlos III Institute (a chair, the secretariat and a bioethicist), and the three
node directors. The Carlos III Institute is the closest equivalent in Spain to the
National Institutes for Health in the USA or to the research section of the Depart-
ment of Health in the UK. It is the central government’s chief funding body and
regulator of scientific research in Spain (Raya and Belmonte, 2009).
If we applied the standards used in the UK model to the Spanish system, six of
these eight members—the three node directors and the three Carlos III Institute
representatives—would be denied membership because of potential conflict of
interest. This form of reasoning did not transfer to the Spanish context, as the
excerpt from a group interview with three members of the Spanish Stem Cell
Bank Steering Committee—the bioethicist, the secretariat and the director of
the Granada node—discussing why the UK director is not allowed to be a full
member of the steering committee, indicates:
Secretariat: It’s not an ethical problem because there are many other people
on the committee.
Granada Node Director: The UK style, for me, it’s like the director of the UK
504 N. Stephens et al.
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Stem Cell Bank is becoming a technician, [but] he should make a decision
about these things, right. That’s why he’s the director of the UK Stem
Cell Bank.
Interviewer: He makes decisions about how to make things happen on a day-
to-day basis, but the long-term strategy is something where he influences the
discussion but is to be decided at steering committee level. That’s the system
that they use.
Secretariat: Yeah. But I don’t understand why he cannot be involved in the
decisions.
This quotation, and the different institutional arrangements they suggest, articulate
different institutional imaginaries of the public. In the UK bank imaginary the
public would not trust these outlined arrangements as they do not instantiate dis-
tance. At the Spanish bank such concerns do not resonate and such safeguards are
deemed unnecessary. Similar observations about the lower profile of conflict of
interest issues have also been reported in the regulation of pre-implantation
genetic testing in Spain compared to the UK (Pavone and Arias, 2011). It is not
that the Spanish steering committee has no concept of conflict of interest and ima-
gines a public unconcerned with this issue. Later in the interview quoted above
they deployed the notion of conflict of interest to explain why the director of
any node cannot pass judgement on the ethical provenance of a hESC line
derived in their own laboratory without support from the rest of the steering com-
mittee. However, their conception of interest is bounded differently, as expressed
by the Spanish committee member’s clear bemusement at the UK director’s
reduced role. In Spain the bank articulates a different imaginary of the public,
with different values resulting in different practice.
We should note that the different constitution of the steering committee is, in
part, due to the existence of a second committee in Spain: the Commission on
Guarantees concerning the Donation and Use of Human Tissues and Cells. This
body is charged with reconciling strategic stem cell research interests with
ethical and legal concerns (Raya and Belmonte, 2009). This commission has 12
members representing scientists, bioethicists and legal practitioners housed at
the Carlos III Institute. While this second committee does take on some of the
remit of the UK Stem Cell Bank Steering Committee, the broader institutional
arrangements of funding and location mean that there is less emphasis on conflicts
of interest than would be the case in the UK. The institutional imaginary of the
public is different, resulting in different institutional articulations by each bank.
Empirical Analysis: Media Profiles and the Stem Cell Banks
We now move on to analyse transcripts from our interviews with the director of
the UK Stem Cell Bank, the director of the lead Granada node of the Spanish
Stem Cell Bank, and the director of the Barcelona node about media interactions.
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All three manage the day-to-day laboratory work of stem cell banking and each is
a figurehead for their institution. All three attend their steering-committee meet-
ings, although the Spanish directors are full committee members with decision-
making powers, while the UK director is not.
The three interviews quoted below were conducted at the respective banks in
2007 and they provided a snapshot of banking practices in both countries at that
time.2 Italics have been added to highlight sections that are pertinent to the analysis.
Director of the UK Stem Cell Bank
The institutional imaginary of the public sustained by the UK bank is evident in
this unfolding account provided by the bank’s director:
Interviewer: What kind of press profile would you like the bank to have?
UK Director: The thing that we’ve attempted to do is to generally be there
supporting the science area in the UK and generally trying to emphasise
the role of the bank and the strength of the regulatory framework in the
UK. Which means that people can be assured that there is a safe professional
organisation involved in the management of the ethically approved lines for
ethically approved work. And that they’re making sure that that’s all open
and above board. And together with the work of the steering committee
that the public can take some confidence in the fact that the UK has this
strong framework and the physical bank to provide a facility to supply ethi-
cally sourced cell lines.
The image which is projected here is of a public that seeks stability. They are to be
assured by professionalism and gain confidence in the openness and the strength of
the UK system. The interview continued:
Interviewer: And how about you personally, do you think that you have a
press profile or should have a press profile?
UK Director: I think it’s been inevitable in the early phases of setting the
bank up since I was the only person in the bank. So my personal presenta-
tions were quite important and as the director of the bank I still continue
to have a certain figurehead role. It’s important to make sure I balance
that, so that I am not appearing for external purposes to compete with the
researchers for press space, so I tend to turn down requests for responses
on stem cell research. I only respond on things which are relevant for us
from the perspectives of the bank’s activities: safety and quality issues.
He later reveals that he has around two or three requests on which to comment
each month, and that this is ‘too many’. This framing of the bank’s remit, and
the projection of a need for ‘balance’, expressed in this extract is also evident
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in the following account by the director about how the chair of the steering com-
mittee relates to the media. However, there are clear differences between these
evaluations that relate to the chair’s role and political identity beyond the bank.
The chair is regarded as an established expert in biomedicine and he has
become a public figure in British politics through his membership of the House
of Lords:
Well [the Chair of the Steering Committee] is involved in the general debates
and they are sort of having to lead it, from the House of Lords primarily. His
role of Chair of the Steering Committee is slightly lower key. I think that’s
sensible because again, as with the bank, you don’t want to be constantly
saying, ‘Hey we’re the steering committee and we’re wonderful and you
should do everything we say’ because you’ll attract some positive press
for a brief while but the danger is you’ll then attract negative press
because I think it’s the tendency once something has been put up on a ped-
estal, the next thing to do for the journalist is to knock it down.
Here the director conjures an image of a public that responds badly to any signs of
grandeur or attention seeking. He also presents himself as aware that contact with
the public is mediated through the agency of journalists who, if provoked, may
portray the bank negatively. It is also significant that, in this excerpt, the director
deals with the boundaries between the bank and the formal political system in
Britain. He highlights the bank’s relationship to established formal political struc-
tures as involving both separation and alignment. Hence, he posits that, while the
steering committee chair, in his role as a member of the House of Lords, may take
the lead in debates about stem cell science, his steering committee role is lower
key. It is evident here that he makes assumptions about the appropriate location
for explicit political engagement. For him, this is the House of Lords, not the
bank or the steering committee. By establishing this demarcation, the director
attempts to reconcile politics and banking.
Towards the end of the interview the UK director returned to the issue of
replying to media requests, while summarising his position:
I think it wouldn’t be helpful for us to constantly respond to everything that
comes along, but to try to maintain a low-level positive awareness in the
public of what we’re doing and what the benefits are to what we’re doing.
So that people just think, ‘Oh it’s something that happens in the UK and
it’s not a big deal. It’s good. It’s positive and there is no reason to be
worried about it’.
These comments suggest that the director of the UK Stem Cell Bank articulates
a particular institutional imaginary of the UK public and of its implication
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in the day-to-day operations of the bank. This is an imaginary in which dis-
tance lends legitimacy and disengagement constitutes correct moral practice.
It involves the bank director presenting himself and the institution as steady,
safe and reliable. It means operating with the presumption that ‘less news
is good news’. The following sections present contrasting accounts from
Spain.
Director of the Granada Node of the Spanish Stem Cell Bank
Like the UK bank, the Spanish bank seeks to satisfy the expectations of its public
but it faces different pressures and engages with the media in a different way. The
following extracts from an interview with the director of the lead node of the bank
in Granada, Andalusia, provide crucial background about the modes of operation
at this bank:
So [stem cells] are a very, very important tool. That’s why I’m here. But I
don’t believe we are going to cure any disease until at least 2020, 2030.
So, if you expect me to go and tell people Andalusia is investing in
human embryonic stem cells and this is very key to cure diabetes, then I
don’t take the job. Because I am telling something in which I don’t
believe . . . But politicians want people to go to the press every single day
telling things like we are going to cure diseases, we are going to cure dia-
betes . . . The media always asks what kind of disease are we going to cure
and when? The politicians need to make sure that the director they hire,
they don’t care whether he’s going to publish or not. But he has to pass
what they call in the [United] States the headline test. He has to give head-
lines to a newspaper.
This is a very different narrative from that offered by the UK director, who ident-
ified the House of Lords as the correct place for political engagement and demon-
strated comfort with this demarcation. In contrast, the Granada director sets
politics and the work of the bank in tension. He describes politicians encouraging
the bank to engage with their public in particular ways with which he is uncom-
fortable. The Granada director continued on this theme when he responded to a
question about how often the bank is mentioned in newspapers:
More than I would like to! Each time we do something, each time we publish
a paper, each time we sign an agreement with a company, each time we hire
scientists: press.
Interviewer: So a press release is issued?
Granada Director: Yes, but not by me. By the politicians . . . [They] say
‘Hey; 12 pm next Monday in this building we will be signing an agreement
that is going to be crucial for the health of the Andalusian people’.
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There is ‘localness’ in play here. While being a global institution, the Granada
node is responding to and anticipating the responses of both the local (autonomy)
public and the national public. There is, of course, also a ‘localness’ to the UK
bank, although in the UK ‘local’ is equated with the national. Localness and pol-
itical culture remains a central theme of the discussion as the following comment
illustrates:
Granada Director: [Politicians] keep saying that we need to win the press, to
make people aware of how important this is and make sure we keep funding
it, because if we are not in the press and the public is not aware of what we
are doing, people will lose interest and people won’t support us, as the
[Andalusian] Government of Health, to invest in the stem cell bank. So we
need to keep celebrating things to make sure that the people who are
going to vote next month are happy with us investing in the bank.
This extract is particularly revealing because it highlights the significance of a
party political agenda in the Spanish bank’s work. In addition, the director
offers an articulation of the needs and preferences of an imagined public in
which voters can be appeased by the bank ‘celebrating things’ and demonstrating
the continued scientific success of the institution. It conjures a public which wants
to see the bank involved in cutting-edge science and successful treatment.
However, we can question who has agency in developing the node’s institutional
imaginary, with clear involvement by politicians encouraging increased press
attention.
The director indicates that the level of press attention was temporarily raised as
a result of the local election scheduled for 27 May 2007. However, it is clear from
the quantity of newspaper coverage he was able to show Neil Stephens from the
preceding two years that the normal level is still high compared to that garnered by
the UK bank. Both inside and outside of election times, engagement with the
media is an important part of stem cell banking life in Granada.
When discussing the forthcoming import of cells from Sweden, the director
described another exchange with local politicians calling for further press cover-
age. In this instance he attributed them as saying ‘[the Swedish group] are giving
[the cells] to us but not the other banks right? . . . It is very important to let people
know that those cells came first to Granada’. This account points once again to the
role of local publics. While the three Spanish nodes operate together to store hESC
material and standardise practice, there is competition for status amongst them.
The UK bank is, of course, involved in competition internationally but, at the
Spanish bank, there is also intra-national competition. It is clear that the
Spanish bank is orientated towards regional audiences in seeking legitimacy
and support. In the next section we consider how the Barcelona director continues
the discussion of the inter-nodal interactions, giving it a somewhat different
texture.
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Director of the Barcelona Node of the Spanish Stem Cell Bank
The Barcelona node is housed in an established stem cell and regenerative medi-
cine centre. The Barcelona and Valencia nodes have both derived hESC lines in-
house and the director suggests that this is their primary function, with the
Granada node operationalising the storage and exchange of tissue between labora-
tories. Despite the differences between the branches, the director of the Barcelona
node maintains a high media profile, as the other members of staff at the bank were
keen to emphasise when I interviewed them:
Barcelona Staff Member: [The bank is] in the Spanish newspaper very often
because [the Barcelona director] is always on the TV, on the radio, in the
newspaper. Normal people in Spain know [the director].
Nevertheless, the director herself was more modest in her claims about her celeb-
rity when she was interviewed:
Interviewer: How do you relate to the media here? People say that you’re in
the press quite often.
Barcelona Director: Nah! Who told you that?
Interviewer: Well, everybody.
Barcelona Director: Everybody! Yeah. Normally it’s the media who come to
us. We don’t go to the media and tell them I have this. It’s the reverse . . .
That’s probably due to my background in assisted reproduction and being in
the first team that achieved a pregnancy in IVF and so on. I have had very
good contact with the media. I think that the relation with the media is quite
important. Because they are the way to get to the society. I mean we have to
explain to everybody what we are doing and this is done through the media.
Interviewer: What kind of message do you want to give through the media to
the public?
Barcelona Director: That in Spain, in Barcelona, we have had the opportunity
to set up a centre like this. Many scientists had come from abroad to be able to
work in here. Regenerative medicine is a very promising field . . . but we have
to be realistic and tell them what is possible and what is not possible and try to
be optimistic but without creating false [hopes].
Like the directors of the UK Stem Cell Bank and the Granada node, the Barce-
lona director was concerned both to let people know that stem cell science is
‘very promising’ but also to be ‘realistic’ about potential outcomes in the
field. As in the Granada case, but in contrast to the UK situation, the Barcelona
director maintains a high media profile. Nevertheless, there seems to be differ-
ences between the strategies of the bank directors in the two Spanish autonomies.
The Barcelona director is less troubled by the media and she seems to feel less
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pressured to place herself under its scrutiny. She expresses less compulsion to
promote both stem cell science and the local autonomous regional bank’s
success in the area.
The conversation then turned to how the local Catalonian autonomous admin-
istration had been initially resistant to the idea of a bank but had subsequently
altered their position. When asked about the local administration’s motivation
to fund the bank, she responded:
It is an emerging field, a new field. And we had the opportunity of getting into
that new field very soon. Spain has not been a country where science has been
very successful for many years because it was not funded and because many
scientists went abroad. We started working on it in 2005 when very few
places were doing derivations. I think that the local administration, the poli-
ticians in Catalonia, saw that this was a fantastic opportunity to start working
with good scientists coming from abroad; I think that this was the main reason.
Comparison between the above extract and those deriving from the interview with
the director of the Granada node demonstrate that they share many views. Both posit
scientific advance as crucial in securing public support for their work, with an
emphasis on the leading role of Spain, and of the local autonomy, against a backdrop
of perceived under-performance. However, the Barcelona director describes a more
harmonious relationship with the media and the local authority.
In certain key aspects, the Spanish directors’ accounts are framed differently
from those of their UK counterpart. As we have suggested, the UK director
couches his account in terms of a degree of disengagement, while those from
Spain are expressed in terms of a more direct and more overtly political mode
of engagement. In that context, the Spanish directors also position themselves
more overtly as spokespersons on behalf of stem cell science itself. Therefore,
the Spanish banks, as represented through these accounts, display distinctively
regional orientations that reflect their understandings of Spain’s political and
social organisation.
Conclusion
This article addresses how two prominent stem cell banks—those of the UK and of
Spain—form institutional imaginaries about the characteristics of the publics to
which they are accountable. It also demonstrates how these institutional imagin-
aries become institutionally articulated, meaning that their ideas about these
publics lead to specific institutional forms and practices. This responds to the
questions identified in the introduction of the paper: how do the banks model
publics and their concerns? How do they see themselves as publicly accountable?
What different patterns arise in the two national cases? How can these differences
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be explained? To summarise our empirical analysis we have followed Jasanoff
and Kim (2009) in producing a table comparing key issues.
Table 1 summarises the institutional imaginaries of the public demonstrated by
each bank and the different institutional arrangements and activities they engen-
der. The structure and modes of operation of each bank are institutional articula-
tions of the particular imaginaries of the public enacted in both contexts. The UK
Stem Cell Bank articulates an imaginary in which distance lends legitimacy and
disengagement signifies correct moral practice. It conjures a public that values a
steady, safe and reliable institution—free from potential conflict of interest—
about which the less news the better. This is in contrast to the Spanish Stem
Cell Bank that conjures a public that retains an interest in legitimate, ethical guar-
dianship of stem cell material, but which is less worried about conflict of interest
in attaining this. Instead, for the Spanish institution, engagement with science and
the media through the projection of the bank as cutting edge is deemed crucial for
maintaining public support.
These differences are set in a context of significant similarity between the two
banks within the diversity of the international sector as a whole. Both are based in
relatively similar countries, with similar stem cell regulation. Both are publicly
funded symbols of their nation’s stem cell portfolio, and both have steering com-
mittees. Indeed, as noted previously, the Spanish bank modelled itself on the UK
Table 1. Comparing institutional imaginaries of publics and the activities they engender
UK Stem Cell Bank Spanish Stem Cell Bank
Model of the public Values steady, safe, scientific
progress (that is also cutting edge)
Values cutting-edge Spanish stem
cell science portfolio (that is also
safe)
How the model of
the public frames
activity
Disengagement: in decision making,
in hESC derivation, in conducting
research
Engagement: in decision making, in
hESC derivation, in conducting
research
Steering committee
make up
Broad and interdisciplinary,
director, funders and government
employees role constrained
Smaller, interdisciplinary, directors,
funders and government
employees fully active members
Research profile Limited to banking processes Aspire to be an international centre in
banking and stem cell research
more broadly
hESC derivation and
embryo storage
Banned Actively pursued
Political
involvement in
the banks’
practices
Implicit, correct political
involvement is positioned in the
House of Lords and other
demarked institutions
Explicit, political interference is set
in tension with the work of the
Granada node, although less so in
Barcelona
Media profile Limited, unsensational, controlled High, politically driven, measured
but engaged
National stem cell
profile
Aspires to be world leading and
ethically secure
Aspires to be world leading and
ethically secure
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version. Nevertheless, as Table 1 shows, differences in the political contexts and
institutional imaginaries of the banks have led the Spanish group to configure their
institution differently.
Our paper develops the work of Jasanoff and Kim (2009) who articulated the
concept of ‘sociotechnical imaginary’ in relation to US and South Korean national
approaches to nuclear energy. We adapt this analytical framework by moving
away from a study of nation states to particular micro-social institutions acting
within nation states: the stem cell banks. This allows us to discuss the institutional
sociotechnical imaginaries, or simply institutional imaginaries, enacted in the UK
and Spanish institutions. We focused on what the institutions intend to achieve, the
mechanisms deemed appropriate for doing so, and how these are put in place. In
doing so, we can detail how these institutions are articulations of particular insti-
tutional imaginaries.
This paper is not an attempt to describe publics; the actual mechanisms by
which people in the UK and Spain make trust judgements about scientific issues
remain as invisible to us as analysts as they do to the banks themselves. Likewise,
we are not suggesting that either one of these systems is better than the other.
Instead, we have sought to demonstrate the role of institutional imaginaries of
publics in shaping the organisational structures and day-to-day practices of two
similar, related organisations. By utilising ethnographic data in this form, our
work demonstrates that these publicly funded institutions are structured by, and
account for themselves in relation to, imagined publics and inferred public
concerns.
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Notes
1This is distinct from another type of stem-cell banking—cord blood banks—that take donations
of cord blood immediately after childbirth for storage either for possible use to meet the child’s
future health needs or that of other people. Cord blood banks are not the focus of this paper.
2The interview reported with the UK director was conducted on 24 July 2007, although this is
one of many conducted with him during the project; the Granada node director was interviewed
on 18 May 2007 and the Barcelona node director on 15 November 2007.
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